CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

Standard

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity. / Ganzer, S; Arlt, Sönke; Schoder, V; Buhmann, Carsten; Mandelkow, E-M; Finckh, U; Beisiegel, U; Naber, Dieter; Müller-Thomsen, T.

In: J NEURAL TRANSM, Vol. 110, No. 10, 10, 2003, p. 1149-1160.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{5ba07c1e1f1646d8a2c92ec0b02e9255,
title = "CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.",
abstract = "This study evaluated the sensitivity and specificity of the cerebrospinal fluid (CSF) levels of tau-protein, amyloid-beta-peptide 1-42 (Abeta1-42), ApoE-genotype and the degree of cognitive decline as diagnostic markers for Alzheimer's disease (AD). Data was obtained from 105 AD patients and 68 controls. Median CSF-tau levels were increased (512 pg/ml vs. 145 pg/ml, p",
author = "S Ganzer and S{\"o}nke Arlt and V Schoder and Carsten Buhmann and E-M Mandelkow and U Finckh and U Beisiegel and Dieter Naber and T M{\"u}ller-Thomsen",
year = "2003",
language = "Deutsch",
volume = "110",
pages = "1149--1160",
journal = "J NEURAL TRANSM",
issn = "0300-9564",
publisher = "Springer",
number = "10",

}

RIS

TY - JOUR

T1 - CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

AU - Ganzer, S

AU - Arlt, Sönke

AU - Schoder, V

AU - Buhmann, Carsten

AU - Mandelkow, E-M

AU - Finckh, U

AU - Beisiegel, U

AU - Naber, Dieter

AU - Müller-Thomsen, T

PY - 2003

Y1 - 2003

N2 - This study evaluated the sensitivity and specificity of the cerebrospinal fluid (CSF) levels of tau-protein, amyloid-beta-peptide 1-42 (Abeta1-42), ApoE-genotype and the degree of cognitive decline as diagnostic markers for Alzheimer's disease (AD). Data was obtained from 105 AD patients and 68 controls. Median CSF-tau levels were increased (512 pg/ml vs. 145 pg/ml, p

AB - This study evaluated the sensitivity and specificity of the cerebrospinal fluid (CSF) levels of tau-protein, amyloid-beta-peptide 1-42 (Abeta1-42), ApoE-genotype and the degree of cognitive decline as diagnostic markers for Alzheimer's disease (AD). Data was obtained from 105 AD patients and 68 controls. Median CSF-tau levels were increased (512 pg/ml vs. 145 pg/ml, p

M3 - SCORING: Zeitschriftenaufsatz

VL - 110

SP - 1149

EP - 1160

JO - J NEURAL TRANSM

JF - J NEURAL TRANSM

SN - 0300-9564

IS - 10

M1 - 10

ER -